Search Results Search Sort by RelevanceMost Recent State of the Art and Science Jan 2004 Treatment of Dependence on Opiate Medications Norman S. Miller, MD Virtual Mentor. 2004;6(1):33-37. doi: 10.1001/virtualmentor.2004.6.1.cprl1-0401. Health Law Jan 2004 Federal Agencies Monitor Physician Prescribing for Pain Amy Young Virtual Mentor. 2004;6(1):30-32. doi: 10.1001/virtualmentor.2004.6.1.hlaw1-0401 In the Literature Apr 2004 Can Medicare Keep Its Contract? Azza M. Jayaprakash, MS Virtual Mentor. 2004;6(4):174-176. doi: 10.1001/virtualmentor.2004.6.4.jdsc2-0404. In the Literature Nov 2003 Physicians' Role in Cost Containment Renee Witlen Virtual Mentor. 2003;5(11):499-502. doi: 10.1001/virtualmentor.2003.5.11.jdsc1-0311. Policy Forum Oct 2003 Psychotropic Medications and Criminal Defendants Robert M. Wettstein, MD Virtual Mentor. 2003;5(10):455-459. doi: 10.1001/virtualmentor.2003.5.10.pfor1-0310 Case and Commentary Jun 2016 Medication Refusal in Schizophrenia: Preventive and Reactive Ethical Considerations James Sabin, MD Overriding a proxy decision maker’s refusal of medication for a psychotic patient is justified when the patient poses a danger to himself or others. AMA J Ethics. 2016;18(6):572-578. doi: 10.1001/journalofethics.2016.18.6.ecas1-1606. Medicine and Society Aug 2016 The Penetrating Gaze and the Decline of the Autopsy William E. Stempsey, MD, PhD Because physicians view autopsies differently than families of the deceased, informed consent rather than permission should be obtained for autopsies. AMA J Ethics. 2016;18(8):833-838. doi: 10.1001/journalofethics.2016.18.8.msoc1-1608. State of the Art and Science Nov 2015 The Challenge of Understanding Health Care Costs and Charges Vineet Arora, MD, MAPP, Christopher Moriates, MD, and Neel Shah, MD, MPP The price transparency movement seeks to make actual medical costs clear to patients and clinicians. AMA J Ethics. 2015;17(11):1046-1052. doi: 10.1001/journalofethics.2015.17.11.stas1-1511. Medical Education Dec 2020 How Educators Can Help Prevent False Brain Death Diagnoses Farah Fourcand, MD and Diana M. Barratt, MD, MPH For many physicians, lack of understanding about brain death leads to confusion and muddles interactions with patients’ loved ones at the end of life. AMA J Ethics. 2020;22(12):E1010-1018. doi: 10.1001/amajethics.2020.1010. Policy Forum Dec 2020 Inconsistency in Brain Death Determination Should Not Be Tolerated Erin Barnes, MD and David Greer, MD, MA Since 1995, the American Academy of Neurology has provided guidelines for brain death determination, but nationwide adherence to these guidelines has been incomplete. AMA J Ethics. 2020;22(12):E1027-1032. doi: 10.1001/amajethics.2020.1027. Pagination First page « First Previous page ‹ Previous … Page 4 Page 5 Page 6 Page 7 Current page 8 Page 9 Page 10 Page 11 Page 12 … Next page Next › Last page Last »
State of the Art and Science Jan 2004 Treatment of Dependence on Opiate Medications Norman S. Miller, MD Virtual Mentor. 2004;6(1):33-37. doi: 10.1001/virtualmentor.2004.6.1.cprl1-0401.
Health Law Jan 2004 Federal Agencies Monitor Physician Prescribing for Pain Amy Young Virtual Mentor. 2004;6(1):30-32. doi: 10.1001/virtualmentor.2004.6.1.hlaw1-0401
In the Literature Apr 2004 Can Medicare Keep Its Contract? Azza M. Jayaprakash, MS Virtual Mentor. 2004;6(4):174-176. doi: 10.1001/virtualmentor.2004.6.4.jdsc2-0404.
In the Literature Nov 2003 Physicians' Role in Cost Containment Renee Witlen Virtual Mentor. 2003;5(11):499-502. doi: 10.1001/virtualmentor.2003.5.11.jdsc1-0311.
Policy Forum Oct 2003 Psychotropic Medications and Criminal Defendants Robert M. Wettstein, MD Virtual Mentor. 2003;5(10):455-459. doi: 10.1001/virtualmentor.2003.5.10.pfor1-0310
Case and Commentary Jun 2016 Medication Refusal in Schizophrenia: Preventive and Reactive Ethical Considerations James Sabin, MD Overriding a proxy decision maker’s refusal of medication for a psychotic patient is justified when the patient poses a danger to himself or others. AMA J Ethics. 2016;18(6):572-578. doi: 10.1001/journalofethics.2016.18.6.ecas1-1606.
Medicine and Society Aug 2016 The Penetrating Gaze and the Decline of the Autopsy William E. Stempsey, MD, PhD Because physicians view autopsies differently than families of the deceased, informed consent rather than permission should be obtained for autopsies. AMA J Ethics. 2016;18(8):833-838. doi: 10.1001/journalofethics.2016.18.8.msoc1-1608.
State of the Art and Science Nov 2015 The Challenge of Understanding Health Care Costs and Charges Vineet Arora, MD, MAPP, Christopher Moriates, MD, and Neel Shah, MD, MPP The price transparency movement seeks to make actual medical costs clear to patients and clinicians. AMA J Ethics. 2015;17(11):1046-1052. doi: 10.1001/journalofethics.2015.17.11.stas1-1511.
Medical Education Dec 2020 How Educators Can Help Prevent False Brain Death Diagnoses Farah Fourcand, MD and Diana M. Barratt, MD, MPH For many physicians, lack of understanding about brain death leads to confusion and muddles interactions with patients’ loved ones at the end of life. AMA J Ethics. 2020;22(12):E1010-1018. doi: 10.1001/amajethics.2020.1010.
Policy Forum Dec 2020 Inconsistency in Brain Death Determination Should Not Be Tolerated Erin Barnes, MD and David Greer, MD, MA Since 1995, the American Academy of Neurology has provided guidelines for brain death determination, but nationwide adherence to these guidelines has been incomplete. AMA J Ethics. 2020;22(12):E1027-1032. doi: 10.1001/amajethics.2020.1027.